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Introduction
Injured axons in adult mammalian central nervous system (CNS) do not spontaneously regenerate to any significant extent, resulting in persistent functional deficits in patients with CNS injury. Evidence suggests that both extracellular inhibitory environment of neurons and age-dependent decline of intrinsic capacity of axon regeneration contribute to the failure of axon regrowth [1] [2] [3] [4] [5] [6] . However the detailed molecular mechanisms underlying axon regeneration failure have not been completely characterized.
Previous research found that glial cells in the CNS environment produce a number of inhibitory molecules that inhibit axon regeneration. These glial-derived inhibitory molecules include Nogo, myelin-associated glycoprotein, oligodendrocyte-myelin glycoprotein, and various types of chondroitin sulphate proteoglycan [2, [7] [8] [9] [10] [11] [12] . Nogo, in particular, which includes three splicing isotypes Nogo-A, B, C, is a major inhibitory molecule. All isotypes contain a 66-amino acid fragment called Nogo-66, which has robust inhibitory activity on axon regeneration [7, 8] . Nogo-66 binds to Nogo receptor 1 (NgR1) to inhibit axon regeneration [13] . However, NgR1 is a glycosylphosphatidylinositol (GPI)-anchored membrane receptor and lacks transmembrane and intracellular domains. Therefore, NgR1 alone cannot directly transduce inhibitory signals of Nogo-66 into the interior of neurons and needs other transmembrane receptor(s) to relay the inhibitory signals. Later studies demonstrated that NgR1 requires two transmembrane proteins, known as neurotrophin receptor p75 (shortly p75) and LINGO-1, to form a functional receptor complex to transduce inhibitory signals of Nogo-66 into the interior of neurons [14] [15] [16] . In this triple-member receptor complex (NgR1/p75/LINGO-1), NgR1 is the only receptor that binds directly to Nogo-66. When binding to Nogo-66, NgR1 recruits p75 and LINGO-1 and tightly binds them together to form a functional receptor complex NgR1/p75/LINGO-1 [14] . It is widely accepted that, upon stimulation by Nogo-66, the receptor complex activates the downstream RhoA-ROCK pathway [17] [18] [19] , which includes small GTPase RhoA and its effectors Rho-associated kinase (ROCK). RhoA-ROCK pathway regulates cytoskeleton, leads to growth cone collapse and finally inhibits axon regeneration [2, 13, 17, 20, 21] .
In addition to inhibitory molecules, neurite growth-promoting factors such as neurotrophins, which can activate intrinsic potential to induce axon growth during axon development and promote axon regeneration after injury, also exist in the intact and injured CNS environment. Nerve growth factor (NGF) is a well-characterized neurotrophin and binds to two transmembrane receptors TrkA and p75 to stimulate neuronal survival and axon regeneration. In the presence of NGF, TrkA and p75 form a receptor complex [22, 23] . By binding to these receptors, NGF activates TrkA signaling, mainly via (mitogenactivated protein kinase kinase)-(extracellular signal-regulated kinase 1/2 (Erk1/2)) and (phosphotidylinositol 3-kinase)-Akt pathways [24] . p75 potentiates TrkA signaling [25, 26] , particularly at low concentrations of NGF [25, [27] [28] [29] by enhancing NGF binding to TrkA receptors [24, 30] . In addition, Ceni et al. recently found that the p75 intracellular domain generated by neurotrophin-induced receptor cleavage potentiated TrkA signaling [31] . Thus by cooperating with TrkA in the presence of NGF, p75 promotes neurite growth and enhances neuron viability.
As mentioned earlier, the binding of Nogo-66 to NgR1/p75/LINGO-1 receptor complex inhibits axon regeneration and induces apoptosis. Therefore, p75 is a common component of two functionally opposed receptor complexes. It is important to investigate the functional interaction of these two complexes in the presence of both ligands (Nogo and NGF), as some neurons such as dorsal root ganglion neurons express NgR1, p75 and TrkA receptors and are exposed to both Nogo and NGF simultaneously at their central branches after CNS injury [32, 33] . In this scenario, Nogo, by enhancing the interaction of NgR1 with p75 [15] , may affect the potentiating role of p75 in NGF-induced TrkA signaling and may interfere with TrkA signaling. If this hypothesis is true, Nogo would suppress TrkA signaling and participate in the inhibition of axon regeneration induced by NGF. To test this possibility, in this study we determined whether Nogo affects TrkA signaling induced by NGF. Because Nogo-A has several inhibitory domains [34] and a 25-amino acid inhibitory peptide sequence (1056-1080 amino acid of rat Nogo-A or 31-55 amino acid of Nogo-66) designated as Nogo-p4 is sufficient to produce core inhibitory properties [8] , we focused our attention on the effects of Nogo-p4 on TrkA signaling using the PC12 cell system as a research model.
Materials and Methods
Cell Culture and treatment As described previously [35] PC12 cells (American Type Culture Collection, Manassas, VA, USA) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% horse serum and 5% fetal bovine serum, 4mM glutamine, 100 units/ml penicillin, and 100 µg/ml streptomycin under humidified conditions in 95% air and 5% CO2 at 37°C. Chinese hamster ovary (CHO) cells were obtained from European Collection of Cell Cultures (ECACC) and cultured in Ham's F12 medium supplemented with 10% fetal bovine serum and 2 mM glutamine. PC12 cells were induced to differentiate into neuron-like cells using 100 ng/ml NGF (R&D Systems, Minneapolis, MN, catalog no. 556-NG) for 7 days. These cells are referred to as 'differentiated' PC12 cells. Differentiated PC12 cells were detached and dispersed with a Pasteur pipette and re-cultured in new plates overnight in a medium containing 1% horse serum and 0.5% fetal calf serum and then treated with Nogo-p4 (Alpha Diagnostics, San Antonio, TX, catalog no. Nogo-P4), a 25-amino acid core inhibitory fragment of Nogo-66 [8] for one hour. NEP1-40 (Calbiochem, San Diego, CA, catalog no. 488230), a specific antagonist of NgR1, was added at the time when needed. PC12 cells were stimulated with NGF for five minutes before extracting protein for western blot.
SDS electrophoresis and western blot analysis
Cells were lysed with cold lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 30 mM MgCl 2 , 0.1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, 1 mM Na 3 VO 4 and protease inhibitor tablet (Roche, Indianapolis, IN, USA)). Protein concentrations were determined using the Bradford protein assay. Equal amounts of protein were separated by SDS-PAGE and electrophoretically transferred onto a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA). The membrane was blocked with 5% low-fat milk in Tris-buffered saline (TBS) (10mM Tris-HCl, 150mM NaCl, pH 7.6) and then incubated with one of the following primary antibodies in 5% bovine serum albumin in Trisbuffered saline with Tween-20 (TTBS) overnight at 4°C: rabbit anti-phosphorylated (1:1000, Cell signaling technology, catalog no. 4060S) or total Akt (1:1000, Cell signaling technology, catalog no. 9272), rabbit antiphosphorylated (1:2000, Cell signaling technology, catalog no. 9101S) or total Erk1/2(1:1000, Cell signaling technology, catalog no. 9102), rabbit anti-TrkA (1:500, Upstate, catalog no. 06-574), rabbit anti-p75 (1:1000, Upstate, catalog no. 07-476), rabbit anti-NgR1 (1:1000, Abcam, catalog no. ab26291), and rabbit anti-LINGO-1 (1:1000, Millipore, catalog no. 07-678). The membranes were incubated with HRP-conjugated goat anti-rabbit secondary antibody (1:2000) at room temperature (about 25°C) for 1 hour. The signals were finally detected by ECL Western blot detection kit (Pierce, Rockford, IL, USA, catalog no. RPN2106). K252a (Calbiochem, La Jolla, CA, USA, catalog no. 402298), an antagonist of Trk receptor inhibitor, was used to block TrkA signaling induced by NGF.
The membranes were re-used and stripped by incubating with Restore Western Blot Stripping Buffer (Pierce, Rockford, IL, USA, catalog no. 21059) according to the manufacturer's instructions. They were then blocked again in 5% low-fat milk in TTBS before reprobing them with mouse anti-β-actin (1:4000, Sigma, catalog no. A2228), rabbit anti-total Erk1/2 (1:1000, Cell signaling technology, catalog no. 9102), or rabbit anti-total Akt (1:1000, Cell signaling technology, catalog no. 9272) antibodies which served as loading control.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from PC12 cells using Trizol reagent (Invitrogen, Frederick, MD, USA, catalog no. 15596-026). One microgram of total RNA was used to synthesize cDNA using Omniscript reverse transcription (RT) kit (Qiagen, Valencia, CA, USA, catalog no. 205110). The reverse transcription step was omitted to serve as the negative control. The primer sequences of PCR were: NgR1 forward, ATGAAGAGGGCGTCCTCCG; NgR1 reverse, TCAGCAGGGCCCAAGCAC; LINGO-1 forward, AGGATGCTGGCAGGGGGTAT; LINGO-1 reverse, CATATCATCTTCATGTTGAACTTGCGG. A 50 μL PCR reaction system using BD Advantage-GC 2 PCR kit (BD Biosciences Clontech, Palo Alto, Calif. catalog no. 639120) was set up as follows: cDNA Template 50 ng (or 50 ng total RNA as negative control), 10X BD Advantage 2 PCR Buffer 5 μl, 50 mM dNTPs (dATP, dCTP, dGTP, and dTTP, 0.2 mmol/l each) 0.5 μl, 100 μM forward and reverse PCR primers 0.5 μl each, 50X BD Advantage 2 Polymerase Mix 1 μl, with sterile water added to a final volume of 50 μl. The thermal conditions of PCR were as follows: denaturation at 95°C for 5 min, 25 cycles of denaturation at 95°C for 30 s, annealing at 55°C for 30 s and extension at 72°C for 1 min. A 10 µl sample of the PCR product was electrophoresed on a 1% agarose gel, stained with SYBR Green I, and visualized on a UV transilluminator.
Construction of NgR1 expressing-plasmids and transfection of PC12 cells
RT-PCR was conducted to clone NgR1 gene from PC12 cells. The primer sequences for PCR cloning of NgR1 were: forward, CCCGAAGATGAAGAGGGCGTCC; reverse, CTGTCCCTGGCTCTGGATGGCG. The RT-PCR product of NgR1 was first inserted into a pTA2 plasmid and then transferred into an expression plasmid pcDNA3.0 to obtain NgR1 expressing-plasmid. The sequence of NgR1 was confirmed by sequencing. Transient transfection of the NgR1 expressing-plasmid and empty plasmid pcDNA3.0 was carried out with Lipofectamine 2000 (Invitrogen, USA, catalog no. 11668-019) according to the manufacturer's instructions. Briefly, 90% confluent PC12 cells in 6-well plates were transfected with 4.0 µg DNA of NgR1 expressingplasmid or empty plasmid. 24 h later, the transfected PC12 cells were differentiated with NGF and the TrkA signaling was analyzed using western blot.
Co-immunoprecipitation
NGF-differentiated PC12 cells were lysed with cold immunoprecipitation buffer: 20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 1% NP-40, 2 μg ml -1 orthovanadate mM phenylmethylsulfonyl fluoride and protease inhibitor tablet (Roche, Indianapolis, IN, USA). Some cells were incubated with Nogo-p4 for 1 h and stimulated with NGF for 5 min prior to protein extraction for co-immunoprecipitation or western blot. Control and experimental lysates were incubated with protein A/G PLUS-Agarose beads (Santa Cruz, catalog no. sc-2003) for 1 h at 4°C to eliminate non-specific binding. The beads were then pelleted by centrifugation at 1,000 x g for 5 min at 4°C. The supernatant (cell lysate) was transferred to a fresh centrifuge tube on ice and anti-NgR1 antibodies (Santa Cruz, catalog no. sc-25659) added for 1 h at 4°C. Then 20 μl resuspended volume of Protein A/G PLUS-Agarose was added and incubated at 4°C on a rocker platform overnight. Immunoprecipitates were obtained by centrifugation at 1,000 x g for 5 min at 4°C. After washing and boiling, samples were used for western blot analysis.
Neurite growth analysis of differentiated PC12 cells NGF-differentiated PC12 cells were detached and dispersed with Pasteur pipette and re-plated onto poly-L-lysine coated 24-well plates in a medium containing 1% horse serum and 0.5% fetal calf serum. NEP1-40, a specific antagonist of NgR1, was added at a final concentration of 1 µM at 14 hours after replating. Nogo-p4 and NGF was added at 15 h and 16 h after re-plating, respectively. The cells were fixed with 4% paraformaldehyde 24 h later. To visualize neurites, PC12 cells were permeabilized with 0.2% Triton X-100 in Phosphate-Buffered Saline (PBS) for 10 min, washed with PBS, and incubated with 200 ng/ml of TRICT-phalloidin (Sigma-Aldrich, St. Louis., MO, USA, catalog no. P1951) for F-actin staining. The images were photographed at ×400 magnification. Five to 10 fields containing a total of at least 100 cells were randomly chosen for neurite growth assay. The neurite length of PC12 cells was measured using STOPSOFTWARE Version 4.6.
Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences version 19.0 software (SPSS Co. Ltd, Chicago, Illinois, USA). Data were expressed as means ± SEM. Significant differences were analyzed using ANOVA followed by LDS multiple comparison test.
Results

NGF induces neurite outgrowth and activates TrkA signaling in PC12 cells
To investigate the effects of Nogo-p4 (a 25-amino acid core inhibitory fragment of Nogo) on NGF-induced TrkA signaling, a suitable cell system should be selected. This cell system should respond to both Nogo-p4 and NGF. PC12 cells are well-known to differentiate into neuron-like cells in the presence of NGF. These NGF-differentiated PC12 cells are commonly used neuronal cell models to investigate NGF-induced TrkA signaling [36] . We first confirmed the response to NGF in our sample PC12 cells. We observed that the cells were round-to-oval in shape with few neurites in normal serum-containing medium (Fig. 1A) . However, after treatment with NGF 100 ng/ml for 1 day cells began to develop neurites (Fig. 1B) . By day 7, almost all cells developed neurites (Fig. 1C) .
Using western blot we also confirmed that the PC12 cells expressed both p75 and TrkA proteins (Fig. 1D) . Phosphorylated Erk1/2 and Akt are widely accepted as key components of TrkA signaling required for NGF-induced neurite outgrowth [24] . Therefore, we selected phosphorylation levels of Erk1/2 and Akt as indicators of TrkA signaling. Western blot showed a small amount of Erk1/2 and Akt in the absence of NGF, whereas NGF treatment for five minutes markedly increased the phosphorylation levels of Erk1/2 and Akt (Fig.  1E) . Signaling was TrkA receptor-dependent because 200 nM K252a, an antagonist of Trk Upon stimulation with 100 ng/ml NGF for 1 day, a few PC12 cells developed neurites. (C) NGF differentiation for 7 days. Incubation with 100 ng/ml NGF for 7 days triggered neurite development in almost all PC12 cells. Scale bar: 50µm. (D) PC12 cells express NGF receptor p75 and TrkA. PC12 cell and CHO cell lysates were resolved by SDS-PAGE. p75 and TrkA proteins were detected by anti-p75 and anti-TrkA antibody. β-actin served as the loading control. Note that p75 and TrkA were detected intensively in PC12 cell lysate but not obviously in CHO cell lysate, which does not express p75 and TrkA, and served as a negative control. CHO: Chinese hamster ovary. (E) NGF stimulation increases the levels of phosphorylated Erk1/2 and Akt. PC12 cells were stimulated with 100 ng/ml NGF for 5 min. The phosphorylated (p-) and total Erk1/2 and Akt were detected using western blot. Note that NGF increased phosphorylation levels of Erk1/2 and Akt, whereas Trk receptor inhibitor K252a blocked its increase.
inhibitor, blocked the NGF-induced increase in phosphorylated Erk1/2 and Akt (Fig.  1E) .
Nogo-p4 inhibits NGF-induced neurite growth through NgR1 in differentiated PC12 cells
We next tested whether PC12 cells also responded to Nogo-p4, a 25-amino acid core inhibitory fragment of Nogo. To simulate a neurite growth system, we first differentiated PC12 cells with NGF, then detached them from the culture plate and re-cultured for neurite growth ( Fig. 2A) . Without NGF, almost no neurite growth occurred in differentiated PC12 cells with or without Nogo-p4 (Fig. 2B, C) . In contrast, treatment with 100 ng/ml NGF alone induced neurite growth in most cells (Fig. 2D) . The extent of neurite growth was significantly reduced by 51% by co-addition of 4 μM Nogo-p4 (Fig. 2E, F) . These results are consistent with a previous report suggesting that Nogo-p4 inhibits neurite growth of PC12 cells [8] and demonstrate that our PC12 cell line responds to both NGF and Nogo-p4.
Next, we examined whether Nogo-p4 inhibition of neurite growth was mediated by Nogo receptor 1 (NgR1) [37] . The mRNA and protein expression of NgR1 and LINGO-1 were cells were treated with NGF for 7 days and re-plated in new plates. NEP1-40, Nogo-p4 and NGF were added at 14 h, 15 h and 16h after re-plating, respectively. Neurite growth analysis was performed at 24 h after treatment with 100 ng/ml NGF. Representative micrograph showing neurite growth of PC12 cells treated with 100 ng/ ml NGF (C), 100 ng/ml NGF + Nogo-p4 (D), 100 ng/ml NGF + NEP1-40 (E), 100 ng/ml NGF + Nogo-p4 + NEP1-40 (F). Scale bar, 50 µm. (G) Quantification of 3 independent experiments was performed by measuring the relative neurite length of differentiated PC12 cells. NGF treatment alone is considered as 100% in each condition. *: p < 0.001((100 ng/ml NGF + Nogo-p4) vs. 100 ng/ml NGF). NS: No significant ((100 ng/ml NGF + NEP1-40) vs. 100 ng/ml NGF ). #: p < 0.001((100 ng/ml NGF + Nogo-p4) vs. (100 ng/ml NGF + Nogo-p4 + NEP1-40)).
Fig. 4.
Nogo-p4 suppresses TrkA signaling induced by 5 ng/ml NGF but not by 100 ng/ml NGF. PC12 neuronal cells were incubated with or without Nogo-p4 for 1 h and then stimulated with or without NGF for 5 min. The phosphorylated (p-) and total Erk1/2 and Akt were detected using western blot. Quantification of 3 independent experiments was performed using Quantity One by measuring the relative phosphorylated/total Erk1/2 or Akt ratio. NGF treatment alone is consi- induced by 100 ng/ml detected using RT-PCR and western blot, respectively. DNA electrophoresis showed that the amplification products of NgR1 and LINGO-1 mRNA were clearly detected by RT-PCR, but not in the control in which the reverse transcription step was omitted (Fig. 3A) . Western blot showed that PC12 cells but not rat liver tissue (which does not express NgR1 and LINGO-1 [13, 14] ) expressed NgR1 and LINGO-1 proteins (Fig. 3B ). NEP1-40, which acts as a selective, competitive and high affinity antagonist of NgR1 [38, 39] was used to block NgR1 interaction with Nogo-p4. Results showed that while Nogo-p4 inhibited NGF-induced neurite growth by 52%, NEP1-40 significantly attenuated the inhibition by 37% (Fig. 3C, D, E, F, G) . These results confirm that the inhibition of neurite growth by Nogo-p4 is at least partly mediated through NgR1. Nogo-p4 does not suppress TrkA signaling induced by 100 ng/ml NGF Using the defined PC12 cell system, we assessed the effects of Nogo-p4 on NGF-induced TrkA signaling. Western blot revealed a small amount of Erk1/2 and Akt phosphorylation in the absence of NGF (Fig. 4A, B) . Nogo-p4 alone did not significantly affect the background levels of Erk1/2 and Akt phosphorylation. As expected, 100 ng/ml NGF markedly induced both Erk1/2 and Akt phosphorylation (Fig. 4A, B) . Unexpectedly, however, 4 μM Nogo-p4 treatment, which inhibits neurite growth (Fig. 2E, F) , did not significantly alter the levels of Erk1/2 and Akt phosphorylation induced by 100 ng/ml NGF (Fig. 4A, B) . To determine if this concentration of Nogo-p4 was too low to affect TrkA signaling, we increased the concentration (10 μM and 40 μM Nogo-p4). Western blot results showed that Nogo-p4 still did not affect TrkA signaling (Fig. 4C, D) . Thus, contrary to our initial prediction, these data did not show that Nogo-p4 affected TrkA signaling induced by 100 ng/ml NGF.
Nogo-p4 suppresses TrkA signaling induced by 5 ng/ml NGF
Compared with in vivo physiological concentrations of NGF, 100 ng/ml NGF is a high level that is commonly used in vitro [40, 41] . Reports suggest that p75 particularly facilitates TrkA signaling in response to a lower concentration of NGF in PC12 cell line and primary neurons [25, 27, 28, 42] . Therefore, we examined whether Nogo-p4 affects TrkA signaling induced by a more physiological level of NGF. Based on previous studies [25] , 5 ng/ml NGF was investigated as a low concentration. Western blot showed that Nogo-p4 alone did not significantly affect the background levels of Erk1/2 and Akt phosphorylation in the absence of NGF, and 5 ng/ml NGF was sufficient to markedly induce the phosphorylation of both Erk1/2 and Akt. However, when Nogo-p4 was added before stimulation with 5 ng/ml NGF, it significantly suppressed the phosphorylation levels of Erk1/2 and Akt (Fig. 4E, F) . These results prompted us to speculate that, while Nogo-p4 does not suppress TrkA signaling induced by high concentrations (100 ng/ml) of NGF, it may suppress signaling induced by low NGF concentrations (5 ng/ml). 
Nogo-4 affects TrkA signaling in a NGF concentration-dependent manner
To determine if Nogo-p4 suppresses TrkA signaling in a concentration-dependent manner, we used NGF concentrations ranging from 1 to 100 ng/ml. Phosphorylation levels of Erk1/2 and Akt decreased as the concentration of NGF decreased from 100 to 1 ng/ml in the absence of Nogo-p4 (Fig. 5 A, B) . Nogo-p4 did not suppress either Erk1/2 or Akt 
The phosphorylated (p-) and total Erk1/2 (A) and Akt (B) were detected using western blot. Quantification of 4 (Erk1/2) or 3 (Akt) independent experiments was performed using Quantity One by measuring the relative phosphorylated/total Erk1/2 (A) or Akt (B) ratio. NGF treatment alone was considered as 1 in each condition. Note that NEP1-40 treatment did not significantly (NS) affect NGF-induced phosphorylation of Erk1/2 (p = 0.326) and Akt (p = 0.434). However it attenuated Nogo-p4 suppression of Erk1/2 and Akt phosphorylation induced by 5 ng/ ml NGF. *: p < 0.001 (A) or p = 0.002 (B).
# : p = 0.004 (A) or p = 0.006 (B). (C, D) Over-expression of NgR1 enhances Nogo-p4 suppression of TrkA signaling induced by low-dose NGF. PC12 cells were transfected with NgR1 expressing plasmid or empty plasmid. 24 h later, transfected PC12 cells were differentiated with NGF. Differentiated PC12 cells were incubated with or without 4 µM Nogo-p4 for 1 h and stimulated with 5 ng/ml NGF for 5 min. The phosphorylated (p-) and total Erk1/2 (C) and Akt (D) were detected using western blot. Quantification of 3 independent experiments was performed using Quantity One by measuring the relative phosphorylated/Erk1/2 (C) or Akt (D) ratio. NGF treatment alone was considered as 1 in each condition. Nogo-p4 significantly suppressed Erk1/2 (*p < 0.001) and Akt (*p < 0.001) phosphorylation induced by 5 ng/ml NGF. Transfection with empty plasmids did not significantly (NS) alter NGF-induced and (Nogo-p4)-suppressed phosphorylation of Erk1/2 (p = 0.285 and p = 0.333, respectively) and Akt (p = 0.683 and p = 0.834, respectively). While transfection with NgR1 expressing-plasmid did not affect Erk1/2 (p = 0.872) and Akt (p = 0.464) phosphorylation, it significantly enhanced Nogo-p4 suppression of NGF-induced Erk1/2 ( # p < 0.001) and Akt ( # p < 0.001) phosphorylation.
phosphorylation induced by 100 and 50 ng/ml NGF, but slightly (although not significantly) suppressed by 25 ng/ml NGF. However Nogo-p4 significantly suppressed TrkA signaling induced by 5 ng/ml and 1 ng/ml NGF ( Fig. 5 A, B) . These results demonstrated that Nogo-p4 affected TrkA signaling in a NGF concentration-dependent manner.
NgR1 mediates Nogo-p4 suppression of TrkA signaling induced by low concentration of NGF
We further investigated whether NgR1 mediates Nogo-p4 suppression of TrkA signaling induced by low concentration of NGF. NEP1-40 [38, 39] was used to block NgR1 binding with Nogo-p4. Results showed that Nogo-p4 significantly suppressed the phosphorylation levels of Erk1/2 induced by 5 ng/ml NGF. While NEP1-40 did not significantly affect NGFinduced phosphorylation of Erk1/2 in the absence of Nogo-p4, it significantly attenuated the phosphorylation of Erk1/2 suppressed by Nogo-p4 (Fig. 6A) . Similarly, NEP1-40 also attenuated the phosphorylation of Akt suppressed by Nogo-p4 (Fig. 6B) suggesting that NgR1 mediated Nogo-p4 suppression of TrkA signaling induced by low concentration of NGF.
To further corroborate that NgR1 mediate the Nogo-p4 suppression of TrkA signaling, NgR1 over-expression experiments were performed. An NgR1 expressing-plasmid was constructed and used to transfect PC12 cells. The effects of Nogo-p4 on TrkA signaling were compared between cells transfected with NgR1 expressing-plasmids and empty plasmids. Results showed that Nogo-p4 significantly suppressed Erk1/2 phosphorylation induced by 5 ng/ml NGF. Transfection with empty plasmids did not affect NGF-induced and (Nogo-p4)-suppressed Erk1/2 phosphorylation. While transfection with NgR1 expressing-plasmid did not affect Erk1/2 phosphorylation, it did enhance Nogo-p4 suppression of TrkA signaling induced by 5 ng/ml NGF (Fig. 6C) . Similarly, transfection with NgR1 expressing-plasmid enhanced Nogo-p4 suppression of Akt phosphorylation induced by 5 ng/ml NGF (Fig.  6D) . These results provide further evidence that Nogo-p4 through NgR1 suppresses TrkA signaling induced by low concentration of NGF.
High but not low concentrations of NGF reduce the formation of NgR1/p75 complexes triggered by Nogo-p4
To further explore the mechanisms of Nogo-p4 suppression of TrkA signaling induced by low concentration of NGF, the interaction of NgR1 and p75 was detected using coimmunoprecipitation experiments. Results showed that in the absence of Nogo-p4 some background p75 could be immunoprecipitated with NgR1. Nogo-p4 enhanced the formation of NgR1/p75 complexes. A high but not low concentration of NGF significantly reduced the levels of NgR1/p75 complexes triggered by Nogo-p4 (Fig. 7) . Fig. 7 . High but not low concentrations of NGF reduce the formation of NgR1/p75 complexes triggered by Nogo-p4. Differentiated PC12 cells were incubated with or without 4 μM Nogo-p4 for 1 h followed by stimulation with NGF for 5 min. Co-immunoprecipitation experiments were performed to detect the formation of NgR1/p75 complexes. Quantification of 3 independent experiments was performed using Quantity One by measuring the NgR1/p75 complexes. Non-treatment was considered as 1 in each condition. *: p < 0.001 (non-treatment vs. Nogo-p4 treatment alone).
# : p = 0.001 (Nogo-p4 treatment alone vs. Nogo-p4 plus 100 ng/ml NGF). NS: not significantly (Nogo-p4 treatment alone vs. Nogo-p4 plus 5 ng/ml NGF, p = 0.097).
Nogo-p4 strongly inhibits neurite growth induced by low concentration of NGF Finally, we asked whether Nogo-p4 effectively inhibits neurite growth induced by low (more physiological) rather than high concentrations of NGF. Neurite growth analysis showed that Nogo-p4 inhibited neurite growth of differentiated PC12 cells by 80% at 5 ng/ ml NGF, but by only 53% at 100 ng/ml NGF (Fig. 8A, B, C, D, E) .These results demonstrated that neurite growth induced by low NGF concentration was strongly inhibited by Nogo-p4 compared with high NGF level.
Discussion
In this study we explored the effects of Nogo-p4, a 25-amino acid core inhibitory fragment of Nogo [8] , on TrkA signaling in differentiated PC12 cells. Our main findings are as follows: 1) Nogo-p4 does not suppress TrkA signaling induced by a high concentration of NGF; 2) Nogo-p4 suppresses TrkA signaling induced by a low concentration of NGF; 3) NgR1 mediates the suppression of TrkA signaling induced by a low concentration of NGF; 4) High but not low concentrations of NGF reduce the formation of NgR1/p75 complexes triggered by Nogo-p4; and 5) suppressed TrkA signaling participates in the inhibition of neurite growth induced by low NGF level.
Nogo is a major inhibitory molecule contributing to axon regeneration failure. The NgR1/LINGO-1/p75 receptor complex mediates inhibitory activity of Nogo. On the other hanbd, the neurotrophin NGF binding with TrkA/p75 receptor complex activates TrkA signaling to promote axon growth. Since p75 is the common receptor of these two receptor Fig. 8 . Nogo-p4 strongly inhibits neurite growth induced by 5 ng/ml NGF. PC12 cells were treated as before (see Fig. 4A ). Representative micrographs of PC12 cells stimulated with 100 ng/ml NGF (A), Nogo-p4 + 100 ng/ ml NGF (B), 5 ng/ml NGF (C) and Nogo-p4 + 5 ng/ml NGF (D) were shown. Scale bar, 50μm. (E) Quantification of 3 independent experiments was performed by measuring the relative length of neurite growth. Nogo-p4 strongly inhibited neurite growth induced by 5 ng/ml NGF compared with100 ng/ml NGF. *: p < 0.001. We confirmed that our cell line expressed NgR1, LINGO-1, p75 and TrkA, and responded to both Nogo-p4 and NGF. Upon stimulation with NGF, TrkA signaling was activated and neurite outgrowths developed in these cells. Furthermore, Nogo-p4 inhibited neurite growth via NgR1. Unexpectedly, 4 μM Nogo-p4 did not significantly affect TrkA signaling induced by 100 ng/ml NGF. Higher concentrations (10 μM and 40 μM) of Nogo-p4 were also ineffective. Because 100 ng/ml NGF is a high, non-physiological concentration usually used to saturate NGF receptor and fully activate TrkA signaling in vitro [41, 43] , we examined the effects of Nogo-p4 on TrkA signaling induced by low (physiological or unsaturated) concentrations of NGF. Under these conditions, Nogo-p4 affected TrkA signaling in a NGF concentration-dependent manner. We also showed that NgR1 antagonist NEP1-40 and NgR1 overexpression attenuated and augmented Nogo-p4 suppression of TrkA signaling induced by low concentration of NGF, respectively. Thus NgR1 mediated Nogo-p4 suppression of TrkA signaling induced by a low concentration of NGF. Finally Nogo-p4 displayed stronger inhibition of neurite growth induced by low NGF concentration compared with neurite growth induced by high NGF levels.
Although we demonstrated that Nogo-p4 interacts with NgR1 to suppress TrkA signaling induced by low concentration of NGF, it is unclear how NgR1 mediates this suppression. It may be explained by the fact that NgR1 recruits p75 to form NgR1/p75 complexes. We found that Nogo-p4 enhanced NgR1 binding with p75 to form NgR1/p75 complexes. High but not low concentrations of NGF reduced the formation of the NgR1/p75 complexes triggered by Nogo-p4. The formation of NgR1/p75 receptor complexes may reduce the amount of p75 available to cooperate with TrkA. Because p75 potentiates TrkA signaling particularly at low concentration of NGF [25, [27] [28] [29] , TrkA signaling induced by low concentration of NGF was significantly suppressed by Nogo-p4 which induces NgR1/p75 complex formation. Therefore, we suggest that Nogo-p4 induces NgR1/p75 receptor complex formation and reduces the amount of p75 available to cooperate with TrkA, and thus suppresses TrkA signaling induced by low concentration of NGF.
Our study has implications for in vivo axon regeneration. It is widely viewed that Nogo-66 exerts inhibitory effects on axon regeneration via NgR1 [13, [44] [45] [46] . The best-characterized pathway mediated by the NgR1 complex involves activation of small GTPase RhoA and its downstream effectors Rho-associated kinase (ROCK), which leads to the phosphorylation of cofilin by LIM kinase to stabilize the growth cone cytoskeleton of damaged axons and inhibit axon regeneration [2, 37] . In addition, the (Nogo-66)-NgR1-EGFR pathway has also been suggested to participate in the inhibition of axon regeneration by Nogo-66 [47] . We show that Nogo-p4 activation of NgR1 selectively suppressed TrkA signaling at low NGF concentrations, leading to inhibition of neurite growth. Therefore, the interaction between the neurite inhibitory Nogo-NgR1 and neurite-promoting NGF-TrkA pathways may be another mechanism of inhibition of axon regeneration in neurons expressing the appropriate receptor complexes.
